Artelo Biosciences Analysis
| ARTLWDelisted Stock | USD 0.01 0.00 0.00% |
Artelo Biosciences is overvalued with Real Value of 0.00532 and Hype Value of 0.007616. The main objective of Artelo Biosciences delisted stock analysis is to determine its intrinsic value, which is an estimate of what Artelo Biosciences is worth, separate from its market price. There are two main types of Artelo Biosciences' stock analysis: fundamental analysis and technical analysis.
The Artelo Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Artelo Biosciences is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Artelo Stock trading window is adjusted to America/New York timezone.
Artelo |
Artelo Stock Analysis Notes
The company recorded a loss per share of 1.43. Artelo Biosciences had not issued any dividends in recent years. Artelo Biosciences, Inc., an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutic treatments. Artelo Biosciences, Inc. was founded in 2011 and is based in La Jolla, California. Artelo Biosciences is traded on BATS Exchange in USA. For more info on Artelo Biosciences please contact Gregory MBA at 858 925 7049 or go to https://www.artelobio.com.Artelo Biosciences Investment Alerts
| Artelo Biosciences is not yet fully synchronised with the market data | |
| Artelo Biosciences has some characteristics of a very speculative penny stock | |
| Artelo Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Artelo Biosciences has accumulated 63 K in total debt. Artelo Biosciences has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Artelo Biosciences' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (10.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Artelo Biosciences has accumulated about 457.33 K in cash with (8.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Artelo Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 13.07 K.Artelo Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Artelo Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Artelo Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Artelo Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Gorgas Gregory D. over six months ago Acquisition by Gorgas Gregory D. of 2600 shares of Artelo Biosciences at 2.051 subject to Rule 16b-3 | ||
Kelly Steven over six months ago Acquisition by Kelly Steven of 22250 shares of Artelo Biosciences at 1.99 subject to Rule 16b-3 |
Artelo Biosciences Predictive Daily Indicators
Artelo Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Artelo Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0056 | |||
| Day Typical Price | 0.0056 |
About Artelo Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Artelo Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Artelo shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Artelo Biosciences. By using and applying Artelo Stock analysis, traders can create a robust methodology for identifying Artelo entry and exit points for their positions.
Artelo Biosciences, Inc., an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutic treatments. Artelo Biosciences, Inc. was founded in 2011 and is based in La Jolla, California. Artelo Biosciences is traded on BATS Exchange in USA.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Artelo Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Artelo Stock
If you are still planning to invest in Artelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Artelo Biosciences' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |